John-Paul Gallivan
Head of Development Co-founder
John-Paul Gallivan, currently serves as our Head of Development at Coultreon Biopharma and has over 15 years of experience in the biotech and pharmaceutical industry.
He joins Coultreon Biopharma from Galapagos, where he was VP and Program Leader for small molecules and antibodies in the development organization.
Prior to that, John-Paul worked at NuCana, a clinical stage, NASDAQ-listed biotech, as VP Clinical Development and Medical Affairs and SVP of Strategy and Lifecycle Management.
John-Paul also gained extensive experience working in a variety of leadership positions in medical, development and strategic functions at Roche, Boehringer-Ingelheim and BMS where he worked on projects in oncology, immunology and infectious diseases.
John-Paul holds a B.Sc in medical microbiology from the University of Edinburgh, and an M.Sc and a Ph.D in virology from Imperial College London.